2m 2m 2m 2m 2m 2m 2m
Helix Biomedix (HXBM)
OTC
$1.02-$0.77 (-43.02%)
Price as of Jul 27, 2026- N/AMarket Cap
- -82.01%1-Year Change
- BiotechnologyIndustry
Helix Biomedix (HXBM)
$1.02-$0.77 (-43.02%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$1.02
$1.02
$1.02
1-Year Range
$1.00
$5.00
$1.02
Latest Close$1.02
Change
-$0.77 (-75.49%)
Volume222
Information as of 07/27/2026
Company Profile
HELIX BIOMEDIX INC
https://www.helixbiomedix.comN/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
19125 Northcreek Parkway, Bothell, WA, United States, 98011
425 402 8400Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington.
Key Executives
- Robin L. Carmichael
Current Ownership Distribution
- Other134,721 (59.95%)
- Insiders89,987 (40.05%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)